![](https://investorshub.advfn.com/uicon/745257.png?cb=1616715579)
Saturday, September 18, 2021 11:55:45 PM
The FDA’s official YouTube channel posted a livestream hours ago where a panel member admits COVID vaccines are killing more people than they’re saving, effectively declaring them ineffective & HIGHLY dangerous.
https://ussanews.com/News1/2021/09/18/fda-panel-discussion-covid-vaccines-are-killing-more-people-than-theyre-saving/
THE NARRATIVE IS CHANGING TO THE FACT THESE EXPERIMENTAL GENETIC THERAPY INJECTIONS ARE DANGEROUS. I PREDICT EMERGENCY USE AUTHORIZATION WILL BE REVOKED AND COMIRNATY WILL THE PULLED FROM THE MARKET.
THE VACCINATED ARE THE EXPERIMENT AND DATA IS SHOWING IT IS NOT WORKING OUT AS EXPECTED!
FOR THE VACCINATED WHAT LIES AHEAD IS IRREVERSIBLE.... AND LETHAL!
The FDA’s official YouTube channel posted a livestream hours ago where a panel member admits COVID vaccines are killing more people than they’re saving, effectively declaring them ineffective & HIGHLY dangerous.
During the stream, one member of the panel began discussed the dangers of the COVID vaccine.
Steve Kirsch, who is the Executive Director of the COVID-19 Early Treatment Fund said that the vaccine is killing more people than it is saving.
The claimed that even if the vaccines were 100% protective, two people are killed for every one life saved.
You heard that correctly..
He vaccines are killing twice as many as they save!
Steve Kirsch: “Even if the vaccines had 100% protection, it still means we kill two people to save one life.”
150,000 people have died due to the vaccines according to Kirsch.
That is 411 deaths per million doses.
The dangers of this experimental “vaccine” have been well hidden, but the truth is there somewhere.
Here is the full livestream:
Recent PFE News
- Cyrus Taraporevala Elected to Pfizer’s Board of Directors • Business Wire • 07/01/2024 10:45:00 AM
- Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron JN.1-adapted COVID-19 Vaccine in the European Union • Business Wire • 06/27/2024 02:30:00 PM
- Pfizer Declares Third-Quarter 2024 Dividend • Business Wire • 06/26/2024 08:30:00 PM
- Pfizer Invites Public to View and Listen to Webcast of July 30 Conference Call with Analysts • Business Wire • 06/18/2024 02:00:00 PM
- Fisker Files for Bankruptcy, Chegg Stocks Rise on 23% Workforce Reduction, and More • IH Market News • 06/18/2024 11:02:13 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/18/2024 01:41:51 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/18/2024 01:41:49 AM
- Adobe Soars 15% Pre-Market; Visa and Mastercard Encounter Hurdles in $30 Billion Agreement, and More • IH Market News • 06/14/2024 11:21:47 AM
- ELREXFIO™ Shows Median Overall Survival of More Than Two Years in People with Relapsed or Refractory Multiple Myeloma • Business Wire • 06/14/2024 07:00:00 AM
- Pfizer Provides Update on Phase 3 Study of Investigational Gene Therapy for Ambulatory Boys with Duchenne Muscular Dystrophy • Business Wire • 06/12/2024 08:30:00 PM
- Form 11-K - Annual report of employee stock purchase, savings and similar plans • Edgar (US Regulatory) • 06/11/2024 06:43:52 PM
- Form 11-K - Annual report of employee stock purchase, savings and similar plans • Edgar (US Regulatory) • 06/11/2024 06:39:34 PM
- Apple Showcases AI at WWDC 2024, Nvidia Stock Split Starts Today, and More News • IH Market News • 06/10/2024 11:29:44 AM
- Relay Therapeutics Announces Clinical Trial Collaboration with Pfizer to Evaluate Atirmociclib in Combination with RLY-2608 • GlobeNewswire Inc. • 06/05/2024 08:05:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/04/2024 09:02:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/04/2024 09:02:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/03/2024 10:34:09 PM
- Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference • Business Wire • 06/03/2024 02:00:00 PM
- Takeda and Pfizer Announce Four-Year Results from Positive Phase 3 HD21 Trial of Additional ADCETRIS® (brentuximab vedotin) Combination in Frontline Hodgkin Lymphoma • Business Wire • 06/01/2024 12:00:00 PM
- Pfizer’s ADCETRIS® Regimen Produces Clinically Meaningful Improvement in Overall Survival in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL) • Business Wire • 06/01/2024 12:00:00 PM
- Form SD - Specialized disclosure report • Edgar (US Regulatory) • 05/31/2024 04:15:11 PM
- Pfizer’s LORBRENA® CROWN Study Shows Majority of Patients with ALK-Positive Advanced Lung Cancer Living Beyond Five Years Without Disease Progression • Business Wire • 05/31/2024 12:00:00 PM
- OpenAI and News Corp Seal Partnership, DuPont de Nemours Announces Division, and More News • IH Market News • 05/23/2024 11:40:51 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/22/2024 04:39:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/16/2024 03:55:06 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM